デフォルト表紙
市場調査レポート
商品コード
1467705

幹細胞バンキング市場レポート:製品タイプ、サービスタイプ、バンクタイプ、使用、用途、地域別、2024~2032年

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
幹細胞バンキング市場レポート:製品タイプ、サービスタイプ、バンクタイプ、使用、用途、地域別、2024~2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞バンキング市場規模は2023年に80億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけての成長率(CAGR)は6.8%を示し、2032年には148億米ドルに達すると予測しています。幹細胞の分離・保存・輸送技術の向上、医療支出の増加、再生医療の進展、非公開会社による多額の投資が、市場を後押しする要因のひとつです。

幹細胞バンキングは画期的な医療の進歩であり、将来への生命線を提供するものです。このプロセスでは、臍帯血や成人組織など様々なソースから幹細胞を保存します。これらの細胞は、白血病からパーキンソン病のような神経変性疾患まで、様々な病気を治療する鍵を握る、驚くべき再生能力を有しています。幹細胞バンキングは、超低温で極低温凍結することにより、これらの生物学的宝物を保護し、何十年もの間、その生存能力を保証します。その意義は大きいです。幹細胞はドナーや遺伝的に適合する親族を治療することができるため、家族は生物学的保険を確保することができ、免疫拒絶反応のリスクを軽減することができます。加えて、幹細胞研究は新たな治療法の発見を続けており、個別化医療における画期的な進歩が期待されています。しかし、費用や認知度が世界的に異なるため、利用しやすさという点では依然として問題があります。幹細胞バンキングは、健康に対する先見的な投資です。患者自身の細胞で衰弱性疾患を治療し、危険な移植の必要性をなくし、医療の新たなフロンティアを切り開く未来を切り開くことができます。この革新的な技術へのアクセスと認知を拡大することは、人類の利益のためにその可能性を最大限に活用するために不可欠です。

世界市場は、がん、糖尿病、心血管系疾患など、さまざまな疾患の治療における幹細胞の可能性に対する意識の高まりによって大きく牽引されています。このような意識の高まりは、幹細胞を用いた治療法の有効性を継続的に実証する広範な調査や臨床試験によって後押しされ、医療関係者や一般市民の想像力をかき立てています。さらに、晩婚化の傾向が拡大し、晩年に子どもを持つことを選択するカップルが増えていることも、臍帯血バンクへの関心を高めています。親は、自分の幼児や家族が将来医療上の困難に直面したときの保険として、新生児の臍帯血幹細胞を保存しておくことの価値を認識しています。さらに、幹細胞バンキングサービスのグローバリゼーションも重要な推進力となっています。凍結保存技術の進歩により、保存された幹細胞の保存期間が延長され、国際的な輸送や国境を越えた利用が可能になりました。これにより、幹細胞バンキングの世界の連携が促進されました。加えて、政府の支援や規制の枠組みが幹細胞バンキングの設立を後押しし、投資や成長に有利な環境が整いつつあります。慢性疾患の増加や幹細胞による個別化治療の可能性は、幹細胞バンキングが将来の医療の極めて重要な要素であることを証明し、市場の継続的な拡大を確実なものにしています。

幹細胞バンキング市場の動向と促進要因:

高齢化人口の増加

高齢化人口の増加は市場にプラスの影響を与えています。この人口動態の変化は、世界的に医療の力学を変化させています。高齢になると、変形性関節症、心血管疾患、アルツハイマー病やパーキンソン病などの神経変性疾患などの変性疾患にかかりやすくなります。幹細胞は、損傷した組織や老化した組織を再生させる上で非常に有望であり、画期的な治療法や高齢者の生活の質を向上させる可能性を提供しています。このような高齢者人口の増加は、より高度な医療ソリューションを求め、幹細胞バンキングサービスの実質的な顧客基盤となります。臍帯血や脂肪組織などから採取された幹細胞を、自分自身や愛する人のために保存しておくことの可能性を、多くの個人や家族が認識しています。これらの保存された幹細胞は、将来、加齢に伴う健康問題に対処するための治療法に使用される可能性があり、安心感と楽観的な気持ちを生み出しています。その結果、幹細胞による再生の可能性に対する高齢化社会の認識が高まり、医療に対するニーズが高まっていることが、幹細胞バンキングサービスの需要増加の原動力となっています。

臨床試験の受け入れ拡大

臨床試験の受け入れ拡大が市場を活性化しています。臨床試験は、がんから脊髄損傷に至るまで、様々な病態における幹細胞治療の安全性と有効性を実証する上で極めて重要です。このような臨床試験の結果が有望視されるにつれ、医療関係者、研究者、一般市民の間で幹細胞治療に対する信頼が高まっています。このような信頼性の高まりは、幹細胞バンキングサービスに対する需要の高まりにもつながっています。臨床試験においては、質の高い幹細胞を容易に入手できる信頼性の高い供給源が必要とされることが多く、幹細胞を専門に保管するバンクはこのような重要なニーズに応えています。研究者や製薬会社は、臨床試験に必要な標準化された保存状態の良い幹細胞サンプルを提供するため、これらのバンクに信頼を寄せており、市場の成長を牽引しています。さらに、臨床試験の良好な結果が再生医療セグメントを発展させ、官民双方からの投資を呼び込むことで、技術革新が促進され、利用可能な幹細胞バンキングサービスの範囲が拡大します。このような研究、受容、投資の好循環が、幹細胞バンキング市場を牽引しているのです。

胚性幹細胞をめぐる倫理的懸念の高まり

胚性幹細胞の使用をめぐる倫理的懸念の高まりが、市場を後押ししています。胚性幹細胞研究は長い間、胚を破壊することによる倫理的議論の対象となっており、その結果、多くの地域で倫理的規制が設けられています。このため、幹細胞研究や治療への応用の焦点は、成体幹細胞や臍帯血のような、議論の余地のない供給源へと移りつつあります。その結果、倫理的な問題を抱えることなく幹細胞治療の潜在的な効果を得ようとする個人や研究機関が、幹細胞バンキングに目を向けるようになりました。特に臍帯血は、倫理的な懸念のない幹細胞の豊富な供給源として脚光を浴びています。家族や医療プロバイダーは、これらの細胞をドナーや潜在的に適合する家族の将来の病気に対する生物学的保険として保存することの価値を認識しています。このような倫理的に健全な幹細胞供給源へのシフトは、多くの幹細胞バンキングの慣行と一致し、より幅広い顧客層を惹きつけ、業界の成長に貢献しています。倫理的な配慮が世論や規制当局の決定に影響を与え続ける中、幹細胞市場は持続的な拡大が期待できます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 幹細胞バンキングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳:製品タイプ別
  • 市場内訳:サービスタイプ別
  • 市場内訳:バンクタイプ別
  • 市場内訳:使用別
  • 市場内訳:用途別
  • 市場内訳:地域別
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 成人幹細胞
  • ヒト胚性幹細胞
  • IPS細胞

第7章 市場内訳:サービスタイプ別

  • サンプル保存・保管
  • サンプル分析
  • サンプル加工
  • サンプル採取と輸送

第8章 市場内訳:バンクタイプ別

  • 民間
  • 公共

第9章 市場内訳:使用別

  • 使用済
  • 未使用

第10章 市場内訳:用途別

  • 個人向けバンキング
  • 研究
  • 臨床

第11章 市場内訳:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ地域
  • ラテンアメリカ

第12章 世界の幹細胞バンキング産業SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 世界の幹細胞バンキング産業:バリューチェーン分析

第14章 世界の幹細胞バンキング産業:ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 世界の幹細胞バンキング産業:価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • CBR Systems Inc.
    • China Cord Blood Corporation
    • Cordlife
    • Cordvida
    • Cryo-Cell International, Inc.
    • Cryo-Save AG(A Group of Esperite)
    • Cryoviva India
    • Lifecell
    • Smart Cells International Ltd
    • Viacord
図表

List of Figures

  • Figure 1: Global: Stem Cell Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Banking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Stem Cell Banking Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Stem Cell Banking Market: Breakup by Service Type (in %), 2023
  • Figure 5: Global: Stem Cell Banking Market: Breakup by Bank Type (in %), 2023
  • Figure 6: Global: Stem Cell Banking Market: Breakup by Utilization (in %), 2023
  • Figure 7: Global: Stem Cell Banking Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Stem Cell Banking Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Stem Cell Banking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Stem Cell Banking Industry: SWOT Analysis
  • Figure 11: Global: Stem Cell Banking Industry: Value Chain Analysis
  • Figure 12: Global: Stem Cell Banking Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Stem Cell Banking (Adult Stem Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Stem Cell Banking (Adult Stem Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Stem Cell Banking (Human Embryonic Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Stem Cell Banking (Human Embryonic Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Stem Cell Banking (IPS Cells) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Stem Cell Banking (IPS Cells) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Stem Cell Banking (Sample Preservation and Storage) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Stem Cell Banking (Sample Preservation and Storage) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Stem Cell Banking (Sample Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Stem Cell Banking (Sample Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Stem Cell Banking (Sample Processing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Stem Cell Banking (Sample Processing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Stem Cell Banking (Sample Collection and Transportation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Stem Cell Banking (Sample Collection and Transportation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Stem Cell Banking (Private) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Stem Cell Banking (Private) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Stem Cell Banking (Public) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Stem Cell Banking (Public) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Stem Cell Banking (Used) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Stem Cell Banking (Used) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Stem Cell Banking (Unused) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Stem Cell Banking (Unused) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Stem Cell Banking (Personalized Banking Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Stem Cell Banking (Personalized Banking Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Stem Cell Banking (Research Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Stem Cell Banking (Research Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Stem Cell Banking (Clinical Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Stem Cell Banking (Clinical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia Pacific: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia Pacific: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Middle East and Africa: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Middle East and Africa: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Latin America: Stem Cell Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Latin America: Stem Cell Banking Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Stem Cell Banking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Stem Cell Banking Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Stem Cell Banking Market Forecast: Breakup by Service Type (in Million US$), 2024-2032
  • Table 4: Global: Stem Cell Banking Market Forecast: Breakup by Bank Type (in Million US$), 2024-2032
  • Table 5: Global: Stem Cell Banking Market Forecast: Breakup by Utilization (in Million US$), 2024-2032
  • Table 6: Global: Stem Cell Banking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Stem Cell Banking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Stem Cell Banking Market Structure
  • Table 9: Global: Stem Cell Banking Market: Key Players
目次
Product Code: SR112024A1152

The global stem cell banking market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing improvements in stem cell isolation, storage, and transportation technologies, the rising healthcare expenditure, the growing progress in regenerative medicine, and the heavy investments by private companies are some of the factors propelling the market.

Stem cell banking, a revolutionary medical advancement, offers a lifeline for the future. This process involves preserving stem cells from various sources, such as umbilical cord blood or adult tissues. These cells possess remarkable regenerative potential, holding the key to treating multiple diseases, from leukemia to neurodegenerative conditions like Parkinson's. Stem cell banking safeguards these biological treasures by cryogenically freezing them at ultra-low temperatures, ensuring their viability for decades. The implications are profound. Families can secure a biological insurance policy, as these cells can treat the donor and genetically compatible relatives, reducing the risk of immune rejection. Additionally, stem cell research continues to unveil new therapeutic applications, promising breakthroughs in personalized medicine. However, accessibility remains an issue, with costs and awareness varying globally. Stem cell banking is a visionary investment in health. It can unlock a future where debilitating diseases are treated with the patient's cells, eliminating the need for risky transplants and opening new frontiers in medical science. Expanding access and awareness of this transformative technology is essential to harness its full potential for the benefit of humanity.

The global market is majorly driven by increasing awareness of the therapeutic potential of stem cells in treating a wide array of diseases, including cancer, diabetes, and cardiovascular conditions. This heightened awareness is fueled by extensive research and clinical trials that continually demonstrate the efficacy of stem cell-based therapies, capturing the imagination of medical professionals and the general public. Furthermore, the expanding trend of delayed parenthood, with more couples opting to have children later in life, has intensified interest in umbilical cord blood banking. Parents recognize the value of preserving their newborn's cord blood stem cells as biological insurance should their child or a family member face a future medical challenge. Moreover, the globalization of stem cell banking services is another key driver. Advances in cryopreservation techniques have extended the shelf life of stored stem cells, allowing for international transportation and cross-border utilization. This has widened the market's reach and fostered worldwide collaboration among stem cell banks. Additionally, government support and regulatory frameworks are becoming more conducive to stem cell banking, fostering a favorable environment for investment and growth. The increasing prevalence of chronic diseases and the potential of stem cells to provide personalized treatments solidifies its position as a pivotal component of future healthcare, ensuring the market's continued expansion.

Stem Cell Banking Market Trends/Drivers:

Increasing aging population

The increasing aging population is positively influencing the market. This demographic shift is transforming healthcare dynamics globally. As individuals age, they become more susceptible to degenerative diseases such as Osteoarthritis, cardiovascular conditions, and neurodegenerative disorders like Alzheimer's and Parkinson's. Stem cells hold immense promise in regenerating damaged or aging tissues, offering the potential for groundbreaking treatments and enhanced quality of life for older people. This growing elderly population demands more advanced healthcare solutions and represents a substantial customer base for stem cell banking services. Several individuals and families recognize the potential of preserving their or their loved ones' stem cells, harvested from sources like cord blood or adipose tissue. These stored stem cells can be used in future therapies to combat age-related health issues, creating a sense of security and optimism. As a result, the aging population's increasing awareness of the regenerative potential of stem cells, coupled with their desire for improved healthcare options, is a driving force behind the rising demand for stem cell banking services, positioning the market for sustained growth in the years to come.

Rising acceptance of clinical trials

The rising acceptance of clinical trials is catalyzing the market. Clinical trials are pivotal in demonstrating the safety and efficacy of stem cell-based therapies across various medical conditions, ranging from cancer to spinal cord injuries. As the results of these trials continue to show promise, confidence in stem cell-based treatments is bolstered among medical professionals, researchers, and the general public. This increasing acceptance translates into greater demand for stem cell banking services. Clinical trials often require a readily accessible and reliable source of high-quality stem cells, and banks specializing in storing these cells meet this critical need. Researchers and pharmaceutical companies rely on these banks to provide the standardized and well-preserved stem cell samples required for their trials, thus driving the market's growth. Furthermore, positive outcomes from clinical trials advance the regenerative medicine field and attract investments from both the public and private sectors, fostering innovation and expanding the range of stem cell banking services available. This virtuous cycle of research, acceptance, and investment propels the market.

Escalating ethical concerns surrounding the use of embryonic stem cells

The escalating ethical concerns surrounding the use of embryonic stem cells are bolstering the market. Embryonic stem cell research has long been a subject of ethical debate due to destroying embryos, resulting in moral and regulatory restrictions in many regions. This has shifted the focus of stem cell research and therapeutic applications towards non-controversial sources, such as adult stem cells and cord blood. As a result, individuals and institutions seeking the potential benefits of stem cell therapies without ethical quandaries are turning to stem cell banking. Cord blood, in particular, has gained prominence as a rich source of stem cells without any ethical concerns. Families and healthcare providers recognize the value of preserving these cells as biological insurance against future illnesses for the donor and potentially compatible family members. This shift towards ethically sound stem cell sources aligns with the practices of most stem cell banks, attracting a broader customer base and contributing to the industry's growth. The market is well-positioned for sustained expansion as ethical considerations continue influencing public opinion and regulatory decisions.

Stem Cell Banking Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, service type, bank type, utilization and application.

Breakup by Product Type:

Adult Stem Cells

Human Embryonic Cells

IPS Cells

Adult stem cells dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes adult stem cells, human embryonic cells, and IPS cells. According to the report, adult stem cells represented the largest segment.

Adult stem cells, also known as somatic or tissue-specific, have emerged as a game-changer in regenerative medicine. These cells are ethically uncontroversial, sourced from bone marrow, adipose tissue, and peripheral blood. Their therapeutic potential in treating various ailments, including orthopedic issues, cardiovascular diseases, and autoimmune disorders, is increasingly recognized.

The rising demand for adult stem cell banking services stems from the growing awareness of their versatility and effectiveness. Patients, physicians, and researchers are considering preserving adult stem cells as a proactive approach to future medical challenges. This demand drives competition and innovation within the industry, resulting in improved storage techniques and expanded service offerings. As regenerative medicine continues to advance, the adult stem cell segment stands as a linchpin in the market's overall expansion, promising personalized healthcare solutions for various conditions and securing its position at the forefront of medical progress.

Breakup by Service Type:

Sample Preservation and Storage

Sample Analysis

Sample Processing

Sample Collection and Transportation

Sample preservation and storage dominate the market

The report has provided a detailed breakup and analysis of the market based on the service type. This includes sample preservation and storage, sample analysis, sample processing, and sample collection and transportation. According to the report, sample preservation and storage represented the largest segment.

Sample preservation and storage segment plays a pivotal role in propelling the market. Stem cell therapies have emerged as a revolutionary medical frontier, promising treatments for various diseases and conditions. Consequently, the demand for safe and reliable storage solutions for precious stem cell samples has skyrocketed. These services offered by stem cell banks ensure these valuable biological assets' long-term viability and potency. This crucial service segment encompasses cutting-edge cryopreservation techniques, state-of-the-art storage facilities, and rigorous quality control measures.

In an era where regenerative medicine is gaining prominence, the efficacy of stem cell treatments hinges on the integrity and accessibility of stored samples. The commitment of stem cell banks to maintaining optimal sample conditions instills confidence in healthcare providers and encourages individuals to invest in stem cell banking for their future medical needs. This rising demand for Sample Preservation and Storage services drives the revenue growth of stem cell banks and fuels advancements in biotechnology and medical research, ultimately paving the way for innovative therapies and improved healthcare outcomes.

Breakup by Bank Type:

Private

Public

Private dominates the market

The report has provided a detailed breakup and analysis of the market based on the bank type. This includes private and public. According to the report, private represented the largest segment.

Private stem cell banks cater to the growing trend of individuals and families taking proactive measures to secure their health and that of their loved ones. These banks offer a unique opportunity for clients to preserve their own or their newborn's stem cells, often sourced from cord blood, for potential future medical needs. This personalized approach to healthcare resonates strongly with a wide demographic, ranging from expectant parents seeking to secure their child's health to adults considering their long-term well-being.

The appeal of private stem cell banks lies in the assurance of access and control over one's biological assets a sense of biological insurance. As medical research unveils novel therapies and applications for stem cells, private banks' convenience and peace of mind are significant drivers of market growth. This segment's emphasis on personalized healthcare aligns with the evolving healthcare landscape, cementing its role in shaping the future of medicine and propelling market growth.

Breakup by Utilization:

Used

Unused

Unused dominates the market

The report has provided a detailed breakup and analysis of the market based on the utilization. This includes used and unused. According to the report, unused represented the largest segment.

The unused segment is equally influential, especially with the growing trend toward proactive healthcare. Individuals and families recognize the intrinsic value of preserving stem cells for potential future use, even without immediate medical need. This preventive approach is reinforced by ongoing research revealing new applications for stem cells. The prospect of securing biological insurance against unforeseen health challenges or benefiting from emerging therapies amplifies the demand for stem cell banking services, further solidifying its position as a dynamic force in modern healthcare.

Furthermore, the used segment reflects the escalating clinical adoption of stem cell-based therapies and treatments, spanning various medical conditions from leukemia to spinal cord injuries. As the effectiveness and safety of these therapies become increasingly established through clinical trials and real-world applications, the demand for access to stored stem cell samples surges. This drives the growth of stem cell banking services as patients and healthcare providers seek reliable sources for viable and high-quality stem cells.

Breakup by Application:

Personalized Banking Applications

Research Applications

Clinical Applications

Clinical applications dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes personalized banking applications, research applications, and clinical applications. According to the report, clinical applications represented the largest segment.

Stem cells hold immense potential in regenerative medicine, and clinical applications harness this potential to treat various medical conditions. From neurological disorders like Parkinson's and Alzheimer's to orthopedic injuries and autoimmune diseases, stem cell-based therapies offer new hope for patients worldwide. The availability of well-preserved and diverse stem cell samples from banks is paramount for successful clinical interventions.

Clinical applications encompass established treatments and cutting-edge therapies in various stages of development, including clinical trials. These applications demand various stem cell types, such as hematopoietic, mesenchymal, and induced pluripotent stem cells, each tailored to specific medical needs. Stem cell banks offering a comprehensive array of these resources contribute significantly to the growth of clinical applications in regenerative medicine.

Furthermore, as research expands our understanding of stem cell biology and therapeutic potential, the clinical landscape is poised for continuous evolution. Consequently, the Clinical Applications segment remains a key driver in the stem cell banking market, fostering innovation and offering renewed optimism for patients seeking novel treatments and improved healthcare outcomes.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America plays a pivotal role in driving the growth of the market. With its advanced healthcare infrastructure, robust research and development activities, and a population increasingly aware of the potential benefits of stem cell therapies, the region stands at the forefront of this burgeoning industry. In the region, stem cell banking is viewed as a proactive health measure and a source of hope for patients suffering from a range of debilitating conditions.

In particular, the United States and Canada have witnessed significant investments in private stem cell banks driven by a combination of healthcare advancements and a culture of health-consciousness. Furthermore, the region's regulatory environment has been relatively supportive, further bolstering market growth by fostering a favorable climate for stem cell banking services.

As clinical trials for stem cell-based therapies expand, and research endeavors continue to flourish in North America, the demand for high-quality stem cell preservation and banking services continues to rise, making this region a powerhouse in shaping the future of stem cell banking.

Competitive Landscape:

Top companies are pivotal in strengthening market growth through a multifaceted approach. These industry leaders invest heavily in cutting-edge research and development, driving innovation in stem cell preservation and analysis techniques. They continually enhance the quality and viability of stored stem cells, instilling confidence in their clients and the medical community. These companies also prioritize extensive collaborations with research institutions, pharmaceutical firms, and healthcare providers. This collaborative spirit fosters the advancement of stem cell-based therapies, expanding their applications and creating a growing demand for banking services. Moreover, top firms actively engage in public awareness campaigns, educating individuals and families about the potential benefits of stem cell banking. This outreach grows the customer base and fuels interest in stem cell research and regenerative medicine. Additionally, their international presence and ability to provide cross-border services amplify market reach and accessibility, further driving growth.

The report has provided a comprehensive analysis of the competitive landscape in the stem cell banking market. Detailed profiles of all major companies have also been provided.

CBR Systems Inc.

China Cord Blood Corporation

Cordlife

Cordvida

Cryo-Cell International, Inc.

Cryo-Save AG (A Group of Esperite)

Cryoviva India

Lifecell

Smart Cells International Ltd

Viacord

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In July 2023, Cordlife announced advanced research on Mesenchymal Stem Cell Secretome-based products for treating Osteoarthritis.

In March 2022, Cryo-Cell International, Inc. revealed its acquisition of a 56,000-square-foot facility in the Research Triangle, North Carolina, within the Regional Commerce Center. This acquisition is contingent upon the fulfillment of standard closing conditions.

Key Questions Answered in This Report

  • 1. What was the size of the global stem cell banking market in 2023?
  • 2. What is the expected growth rate of the global stem cell banking market during 2024-2032?
  • 3. What are the key factors driving the global stem cell banking market?
  • 4. What has been the impact of COVID-19 on the global stem cell banking market?
  • 5. What is the breakup of the global stem cell banking market based on the product type?
  • 6. What is the breakup of the global stem cell banking market based on the service type?
  • 7. What is the breakup of the global stem cell banking market based on the bank type?
  • 8. What is the breakup of the global stem cell banking market based on the utilization?
  • 9. What is the breakup of the global stem cell banking market based on the application?
  • 10. What are the key regions in the global stem cell banking market?
  • 11. Who are the key players/companies in the global stem cell banking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Service Type
  • 5.6 Market Breakup by Bank Type
  • 5.7 Market Breakup by Utilization
  • 5.8 Market Breakup by Application
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Adult Stem Cells
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Embryonic Cells
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IPS Cells
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Service Type

  • 7.1 Sample Preservation and Storage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sample Analysis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sample Processing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sample Collection and Transportation
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Bank Type

  • 8.1 Private
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Public
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Utilization

  • 9.1 Used
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Unused
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Personalized Banking Applications
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Applications
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Clinical Applications
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Stem Cell Banking Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Stem Cell Banking Industry: Value Chain Analysis

14 Global Stem Cell Banking Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Stem Cell Banking Industry: Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 CBR Systems Inc.
    • 16.3.2 China Cord Blood Corporation
    • 16.3.3 Cordlife
    • 16.3.4 Cordvida
    • 16.3.5 Cryo-Cell International, Inc.
    • 16.3.6 Cryo-Save AG (A Group of Esperite)
    • 16.3.7 Cryoviva India
    • 16.3.8 Lifecell
    • 16.3.9 Smart Cells International Ltd
    • 16.3.10 Viacord